ES2062266T3 - Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas. - Google Patents

Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Info

Publication number
ES2062266T3
ES2062266T3 ES90121632T ES90121632T ES2062266T3 ES 2062266 T3 ES2062266 T3 ES 2062266T3 ES 90121632 T ES90121632 T ES 90121632T ES 90121632 T ES90121632 T ES 90121632T ES 2062266 T3 ES2062266 T3 ES 2062266T3
Authority
ES
Spain
Prior art keywords
infections
isoquinolyloxazole
onas
quinolyl
glycoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90121632T
Other languages
English (en)
Inventor
Sai P Sunkara
Winton D Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2062266T3 publication Critical patent/ES2062266T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A LAS QUINOLIXAZOLE-2-ONAS NECESARIAS COMO AGENTES ANTI VIRUS CUBIERTOS POR VIRTUD DE SU CAPACIDAD PARA ACTUAR COMO INHIBIDORAS DE LA PROTEINA QUINASA C. ESTOS DERIVADOS SE EXPONEN COMO EFECTIVOS EN EL TRATAMIENTO DE INFECCIONES POR VIRUS CUBIERTOS INCLUYENDO LAS INFECCIONES HIV Y SON UTILES TAMBIEN PARA EL TRATAMIENTO DEL SIDA Y EL ARC.
ES90121632T 1989-11-13 1990-11-12 Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas. Expired - Lifetime ES2062266T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43531889A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
ES2062266T3 true ES2062266T3 (es) 1994-12-16

Family

ID=23727911

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90121632T Expired - Lifetime ES2062266T3 (es) 1989-11-13 1990-11-12 Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Country Status (11)

Country Link
EP (1) EP0428105B1 (es)
JP (1) JP2927930B2 (es)
KR (1) KR0162639B1 (es)
AT (1) ATE100318T1 (es)
AU (1) AU630249B2 (es)
DE (1) DE69006187T2 (es)
DK (1) DK0428105T3 (es)
ES (1) ES2062266T3 (es)
IE (1) IE63851B1 (es)
PH (1) PH27309A (es)
ZA (1) ZA908933B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Also Published As

Publication number Publication date
JP2927930B2 (ja) 1999-07-28
DK0428105T3 (da) 1994-02-28
IE63851B1 (en) 1995-06-14
IE904079A1 (en) 1991-05-22
KR910009260A (ko) 1991-06-28
ATE100318T1 (de) 1994-02-15
KR0162639B1 (ko) 1998-12-01
PH27309A (en) 1993-05-28
EP0428105B1 (en) 1994-01-19
JPH03173886A (ja) 1991-07-29
ZA908933B (en) 1991-08-28
AU6592990A (en) 1991-05-16
DE69006187D1 (de) 1994-03-03
EP0428105A2 (en) 1991-05-22
DE69006187T2 (de) 1994-05-05
AU630249B2 (en) 1992-10-22
EP0428105A3 (en) 1991-12-11

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
EA199901031A1 (ru) Производные бензимидазола
FI862011A (fi) Terapeutiska nukleosider.
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
IT1216686B (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ATE82294T1 (de) Therapeutische nukleoside.
MX9805441A (es) Compuestos terapeuticos.
DE68900760D1 (de) Virushemmende nukleosidmischung.
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ATE383161T1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
YU221289A (en) Antivirus compounds
HUT71422A (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections
DE69010736D1 (de) Anti-HIV Zusammensetzungen.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
MD421C2 (ro) Derivaţi ai aminoacizilor şi sărurile acido-aditive ale acestora

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 428105

Country of ref document: ES